Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04245085
Title ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma (ABC-lung)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Thoracic Oncology Platform
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP | DEU


No variant requirements are available.